Chief Technology Officer · Disc Medicine, Inc. (IRON)

Scott Lauder

FY2020 is the first fiscal year CompBrief holds for Scott Lauder as a named executive officer of Disc Medicine; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$616,817

Salary $355,000Stock awards $0Bonus $117,800

3rd of 3 named executive officers at Disc Medicine by FY2020 total.

3 named officers on file for Disc Medicine, FY2020

Scott Lauder’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 3 equity grants, each cited to its filing
  • IRON’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Disc Medicine’s whole pay program stands against its peers

  • Disc Medicine’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IRON→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed August 17, 2021 (DEF 14A).

Free

Get Scott Lauder’s full pay file as a PDF — free

More than this page: up to 10 years of Scott’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Scott Lauder compensation by year

Disc Medicine Summary Compensation Table · the one fiscal year held
In US dollars, as Disc Medicine reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020
Salary$355,000
Bonus$117,800
Stock awards$0
Option awards$136,517
Non-equity incentive$0
Pension and deferred compensation$0
All other$7,500
Total$616,817

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Disc Medicine, Inc. DEF 14A filed August 17, 2021, accession 0001193125-21-248368, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Disc Medicine, Inc. filed document, accession 0001193125-21-248368. Every figure is read from that document and cited to the page and table it appears in. Filed August 17, 2021.

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU46,250$76,775—
Option78,400—$0.28
Option75,000—$0.55
Option96,971—$1.66

Per the Outstanding Equity Awards at Fiscal Year-End table in Disc Medicine, Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Disc Medicine’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Jason MeyenburgChief Executive Officer and President$2,071,294
Marc UknisChief Medical Officer$1,556,725
Scott Lauder · this pageChief Technology Officer$616,817

The full Disc Medicine compensation record

free company brief

This page is one person within Disc Medicine's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Disc Medicine proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Disc Medicine's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Scott Lauder's compensation dossier · One-time report. No refunds.